A detailed history of Tower Research Capital LLC (Trc) transactions in Cartesian Growth Corp Ii stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 51 shares of RENE stock, worth $587. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51
Previous 58 12.07%
Holding current value
$587
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$11.1 - $11.28 $77 - $78
-7 Reduced 12.07%
51 $0
Q1 2024

May 15, 2024

SELL
$10.97 - $11.12 $2,654 - $2,691
-242 Reduced 80.67%
58 $0
Q4 2023

Feb 13, 2024

SELL
$10.8 - $10.96 $2,170 - $2,202
-201 Reduced 40.12%
300 $3,000
Q3 2023

Nov 14, 2023

BUY
$10.68 - $10.88 $5,350 - $5,450
501 New
501 $5,000
Q1 2023

May 09, 2023

BUY
$10.25 - $10.51 $1,014 - $1,040
99 New
99 $1,000

Others Institutions Holding RENE

About Cartesian Growth Corp II


  • Ticker RENE
  • Exchange NASDAQ
  • Sector Financial Services
  • Industry Shell Companies
  • Shares Outstandng 23,000,000
  • Market Cap $265M
  • Description
  • Cartesian Growth Corporation II focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in New York, New York.
More about RENE
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.